R-906289 Monosodium

N/A

Report date: 2025/08/09 20:00:10
NME

Base Information

Drug NameR-906289 Monosodium
Drug Alias NameR906289 MonosodiumR-906289R-289 NaR289 NaR-289
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 1 inhibitorsInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 1Interleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesRigel Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A